|
May 8
|
UPDATE -- Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
|
|
May 8
|
Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
|
|
May 7
|
Aspira Women’s Health Announces Publication of Two OvaWatch Peer-Reviewed Manuscripts
|
|
May 2
|
Aspira Women’s Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatch
|
|
Apr 9
|
Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
|
|
Mar 28
|
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
|
|
Mar 25
|
Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call
|
|
Mar 21
|
Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference
|
|
Mar 18
|
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President
|
|
Mar 11
|
Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024
|
|
Feb 22
|
Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference
|
|
Dec 19
|
Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024
|
|
Dec 8
|
New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT
|
|
Dec 7
|
New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT
|
|
Dec 6
|
Aspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis
|
|
Nov 28
|
Aspira Women’s Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)
|
|
Nov 27
|
Aspira Women’s Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS)
|
|
Sep 29
|
Aspira Women’s Health to Present at the BioVenture Nexus Conference
|
|
Aug 9
|
Aspira Women’s Health Announces Transition of its Chief Scientific Officer/Chief Operating Officer
|
|
Jun 28
|
Aspira Women’s Health, Inc. Received a $1 MM Loan Forgiveness and 6-Month Payment Deferral from the CT DECD
|